Literature DB >> 27467946

Linking cancer-induced Nlrp3 inflammasome activation to efficient NK cell-mediated immunosurveillance.

Maryse Dagenais1, Maya Saleh2.   

Abstract

We have recently demonstrated that the Nlrp3 inflammasome can detect the presence of colorectal cancer (CRC) metastatic growth in the liver and limit its growth. Inflammasome signaling primed natural killer (NK) cells through Interleukin (IL)-18 and activated their ability to trigger FasL-induced apoptosis of the tumor.

Entities:  

Keywords:  Apoptosis; Fas; NK cells; Nlrp3 inflammasome; cancer; immunosurveillance; immunotherapy; innate immunity

Year:  2016        PMID： 27467946      PMCID： PMC4910718          DOI： 10.1080/2162402X.2015.1129484

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  10 in total

1.  Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells.

Authors:  Magali Terme; Evelyn Ullrich; Laetitia Aymeric; Kathrin Meinhardt; Jérôme D Coudert; Mélanie Desbois; François Ghiringhelli; Sophie Viaud; Bernard Ryffel; Hideo Yagita; Lieping Chen; Salaheddine Mécheri; Gilles Kaplanski; Armelle Prévost-Blondel; Masashi Kato; Joachim L Schultze; Eric Tartour; Guido Kroemer; Mariapia Degli-Esposti; Nathalie Chaput; Laurence Zitvogel
Journal:  Cancer Res       Date:  2012-03-16       Impact factor: 12.701

Review 2.  Targeting natural killer cells and natural killer T cells in cancer.

Authors:  Eric Vivier; Sophie Ugolini; Didier Blaise; Christian Chabannon; Laurent Brossay
Journal:  Nat Rev Immunol       Date:  2012-03-22       Impact factor: 53.106

Review 3.  Innate immune mechanisms of colitis and colitis-associated colorectal cancer.

Authors:  Maya Saleh; Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

Review 4.  Evolving synergistic combinations of targeted immunotherapies to combat cancer.

Authors:  Ignacio Melero; David M Berman; M Angela Aznar; Alan J Korman; José Luis Pérez Gracia; John Haanen
Journal:  Nat Rev Cancer       Date:  2015-08       Impact factor: 60.716

5.  Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses.

Authors:  Johan Garaude; Andrew Kent; Nico van Rooijen; J Magarian Blander
Journal:  Sci Transl Med       Date:  2012-02-08       Impact factor: 17.956

6.  The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity.

Authors:  Jeremy Dupaul-Chicoine; Azadeh Arabzadeh; Maryse Dagenais; Todd Douglas; Claudia Champagne; Alexandre Morizot; Ian Gaël Rodrigue-Gervais; Valérie Breton; Sara L Colpitts; Nicole Beauchemin; Maya Saleh
Journal:  Immunity       Date:  2015-09-15       Impact factor: 31.745

7.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.

Authors:  François Ghiringhelli; Lionel Apetoh; Antoine Tesniere; Laetitia Aymeric; Yuting Ma; Carla Ortiz; Karim Vermaelen; Theocharis Panaretakis; Grégoire Mignot; Evelyn Ullrich; Jean-Luc Perfettini; Frédéric Schlemmer; Ezgi Tasdemir; Martin Uhl; Pierre Génin; Ahmet Civas; Bernhard Ryffel; Jean Kanellopoulos; Jürg Tschopp; Fabrice André; Rosette Lidereau; Nicole M McLaughlin; Nicole M Haynes; Mark J Smyth; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2009-09-20       Impact factor: 53.440

Review 8.  Activation and regulation of the inflammasomes.

Authors:  Eicke Latz; T Sam Xiao; Andrea Stutz
Journal:  Nat Rev Immunol       Date:  2013-06       Impact factor: 53.106

9.  Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium.

Authors:  Maria Teresa Carrascal; Lorea Mendoza; Maria Valcárcel; Clarisa Salado; Eider Egilegor; Naiara Tellería; Fernando Vidal-Vanaclocha; Charles A Dinarello
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

Review 10.  Nod-like receptors: key molecular switches in the conundrum of cancer.

Authors:  Andrew Kent; J Magarian Blander
Journal:  Front Immunol       Date:  2014-04-23       Impact factor: 7.561
  10 in total
  10 in total

Review 1.  Targeting the NLRP3 inflammasome in inflammatory diseases.

Authors:  Matthew S J Mangan; Edward J Olhava; William R Roush; H Martin Seidel; Gary D Glick; Eicke Latz
Journal:  Nat Rev Drug Discov       Date:  2018-07-20       Impact factor: 84.694

2.  TAK1ng control: TAK1 restrains NLRP3 activation.

Authors:  Matthew Stephen Mangan; Eicke Latz
Journal:  J Exp Med       Date:  2018-03-05       Impact factor: 14.307

Review 3.  NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development.

Authors:  Patricia Ahechu; Gabriel Zozaya; Pablo Martí; José Luis Hernández-Lizoáin; Jorge Baixauli; Xabier Unamuno; Gema Frühbeck; Victoria Catalán
Journal:  Front Immunol       Date:  2018-12-11       Impact factor: 7.561

Review 4.  Inflammasome: A Double-Edged Sword in Liver Diseases.

Authors:  Jingyun Luan; Dianwen Ju
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

Review 5.  Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy.

Authors:  Dev Karan
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

6.  Absent in melanoma 2 enhances anti-tumour effects of CAIX promotor controlled conditionally replicative adenovirus in renal cancer.

Authors:  Dafei Chai; Dong Qiu; Zichun Zhang; Shang Yuchen Shi; Gang Wang; Lin Fang; Huizhong Li; Hailong Li; Hui Tian; Junnian Zheng
Journal:  J Cell Mol Med       Date:  2020-07-29       Impact factor: 5.310

7.  Low NLRP3 expression predicts a better prognosis of colorectal cancer.

Authors:  Feng Shi; Bo Wei; Tian Lan; Yang Xiao; Xin Quan; Jun Chen; Chong Zhao; Jinhang Gao
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

8.  Prognostic Role of Inflammasome Components in Human Colorectal Cancer.

Authors:  Charlotte Domblides; Isabelle Soubeyran; Lydia Lartigue; Isabelle Mahouche; Félix Lefort; Valérie Velasco; Thomas Barnetche; Patrick Blanco; Julie Déchanet-Merville; Benjamin Faustin
Journal:  Cancers (Basel)       Date:  2020-11-24       Impact factor: 6.639

Review 9.  Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities.

Authors:  Ester García-Pras; Anabel Fernández-Iglesias; Jordi Gracia-Sancho; Sofía Pérez-Del-Pulgar
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

Review 10.  Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks.

Authors:  Ting-Yi Lin; Meng-Chun Tsai; Wei Tu; Hsin-Chih Yeh; Shu-Chi Wang; Shu-Pin Huang; Chia-Yang Li
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.